日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES)

更正:Roxadustat 用于治疗未接受透析的慢性肾脏病患者贫血:一项 3 期随机、开放标签、活性对照研究 (DOLOMITES)

Barratt, Jonathan; Andric, Branislav; Tataradze, Avtandil; Schömig, Michael; Reusch, Michael; Valluri, Udaya; Mariat, Christophe

Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS)

罗沙司他用于治疗未接受透析的慢性肾脏病患者贫血:一项 3 期随机、双盲、安慰剂对照研究 (ALPS)

Shutov, Evgeny; Sułowicz, Władysław; Esposito, Ciro; Tataradze, Avtandil; Andric, Branislav; Reusch, Michael; Valluri, Udaya; Dimkovic, Nada

Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)

罗沙司他用于治疗未接受透析的慢性肾脏病患者贫血:一项 3 期随机、开放标签、活性对照研究 (DOLOMITES)

Barratt, Jonathan; Andric, Branislav; Tataradze, Avtandil; Schömig, Michael; Reusch, Michael; Valluri, Udaya; Mariat, Christophe